Alnylam Pharmaceuticals (ALNY) PT Lowered to $448 at Bernstein SocGen
April 24, 2026 8:34 AM
Bernstein SocGen Group analyst William Pickering lowered the price target on Alnylam Pharmaceuticals (NASDAQ: ALNY) to $448.00 (from $451.00) while ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
